Status:
RECRUITING
[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Carcinoma
Eligibility:
MALE
21+ years
Phase:
NA
Brief Summary
This clinical trial evaluates \[18F\]-rh PSMA positron emission tomography (PET)-computed tomography (CT) imaging performance in patients with prostate cancer. PET is an established imaging technique ...
Detailed Description
PRIMARY OBJECTIVE: I. To evaluate the imaging performance of flotufolastat F-18 gallium (\[18F\]-rhPSMA) PET-CT imaging subsystem of the RefleXion Medical Radiotherapy System Device in patients with ...
Eligibility Criteria
Inclusion
- Documented informed consent of the participant and/or legally authorized representative
- Age: ≥ 21 years
- Patients with SOC \[18F\]-RhPSMA PET-CT in whom a PET avid lesion is identified
- Able to get same day X1 RMRS PET
Exclusion
- Known psychiatric or substance abuse disorder that would interfere with conduct of the study
- Patient weight exceeding the weight limit (450 pounds) outlined per X1 RMRS specifications sheet
Key Trial Info
Start Date :
March 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 9 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06580015
Start Date
March 25 2025
End Date
January 9 2027
Last Update
July 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010